TR200103405T2 - İkiişlevli antikorlar ve bunların tümör-önleyici amilleri hedeflemede kullanımı. - Google Patents
İkiişlevli antikorlar ve bunların tümör-önleyici amilleri hedeflemede kullanımı.Info
- Publication number
- TR200103405T2 TR200103405T2 TR2001/03405T TR200103405T TR200103405T2 TR 200103405 T2 TR200103405 T2 TR 200103405T2 TR 2001/03405 T TR2001/03405 T TR 2001/03405T TR 200103405 T TR200103405 T TR 200103405T TR 200103405 T2 TR200103405 T2 TR 200103405T2
- Authority
- TR
- Turkey
- Prior art keywords
- inhibiting agents
- bifunctional antibodies
- targeting tumor
- treatment
- targeting
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 230000001588 bifunctional effect Effects 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 230000008685 targeting Effects 0.000 title 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- 239000002254 cytotoxic agent Substances 0.000 abstract 1
- 231100000599 cytotoxic agent Toxicity 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9819411.1A GB9819411D0 (en) | 1998-09-04 | 1998-09-04 | Antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200103405T2 true TR200103405T2 (tr) | 2002-06-21 |
Family
ID=10838416
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2001/03405T TR200103405T2 (tr) | 1998-09-04 | 1999-09-06 | İkiişlevli antikorlar ve bunların tümör-önleyici amilleri hedeflemede kullanımı. |
| TR2001/00651T TR200100651T2 (tr) | 1998-09-04 | 1999-09-06 | İki işlevli antikorlar ve bunların tümör-önleyici amilleri hedeflemede kullanımı |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2001/00651T TR200100651T2 (tr) | 1998-09-04 | 1999-09-06 | İki işlevli antikorlar ve bunların tümör-önleyici amilleri hedeflemede kullanımı |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1107995A2 (xx) |
| JP (1) | JP2002524470A (xx) |
| KR (1) | KR20010072988A (xx) |
| CN (1) | CN1315967A (xx) |
| AU (1) | AU5641299A (xx) |
| BG (1) | BG105293A (xx) |
| BR (1) | BR9913429A (xx) |
| CA (1) | CA2341753A1 (xx) |
| EA (1) | EA200100311A1 (xx) |
| GB (1) | GB9819411D0 (xx) |
| HR (1) | HRP20010154A2 (xx) |
| HU (1) | HUP0104091A2 (xx) |
| ID (1) | ID28873A (xx) |
| IL (1) | IL141524A0 (xx) |
| MX (1) | MXPA01002349A (xx) |
| NO (1) | NO20011102L (xx) |
| PL (1) | PL346861A1 (xx) |
| TR (2) | TR200103405T2 (xx) |
| WO (1) | WO2000014119A2 (xx) |
| ZA (1) | ZA200101574B (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11987629B2 (en) | 2018-06-01 | 2024-05-21 | Tayu Huaxia Biotech Medical Group Co., Ltd. | Compositions and uses thereof for treating disease or condition |
| WO2019227490A1 (en) | 2018-06-01 | 2019-12-05 | Tayu Huaxia Biotech Medical Group Co., Ltd. | Compositions and methods for imaging |
| EP3826673A4 (en) * | 2018-07-26 | 2022-03-09 | Tayu Huaxia Biotech Medical Group Co., Ltd. | COMPOSITIONS AND METHODS FOR IMAGING |
| CN113795511B (zh) | 2019-01-23 | 2024-07-23 | 大有华夏生物医药集团有限公司 | 抗pd-l1双抗体及其用途 |
| CN110811820B (zh) * | 2019-12-11 | 2022-07-12 | 江西华晨医疗设备有限公司 | 一种直杆式冲洗吸引电凝切割器 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4474893A (en) * | 1981-07-01 | 1984-10-02 | The University of Texas System Cancer Center | Recombinant monoclonal antibodies |
| IL89491A0 (en) * | 1988-11-17 | 1989-09-10 | Hybritech Inc | Bifunctional chimeric antibodies |
| US5217713A (en) * | 1988-12-27 | 1993-06-08 | Takeda Chemical Industries, Ltd. | Cytotoxic bispecific monoclonal antibody, its production and use |
| CA2069439A1 (en) * | 1989-12-15 | 1991-06-16 | Susumu Iwasa | Monoclonal antibodies, their production and use |
| JPH05184383A (ja) * | 1990-06-19 | 1993-07-27 | Dainabotsuto Kk | 二重特異性抗体 |
| WO1998038513A1 (en) * | 1997-02-26 | 1998-09-03 | Khaw Ban An | Signal enhancement of bispecific antibody-polymer probe for immunoassay use |
-
1998
- 1998-09-04 GB GBGB9819411.1A patent/GB9819411D0/en not_active Ceased
-
1999
- 1999-09-06 CN CN99810368A patent/CN1315967A/zh active Pending
- 1999-09-06 KR KR1020017002437A patent/KR20010072988A/ko not_active Withdrawn
- 1999-09-06 MX MXPA01002349A patent/MXPA01002349A/es not_active Application Discontinuation
- 1999-09-06 WO PCT/GB1999/002938 patent/WO2000014119A2/en not_active Ceased
- 1999-09-06 HU HU0104091A patent/HUP0104091A2/hu unknown
- 1999-09-06 ID IDW20010752A patent/ID28873A/id unknown
- 1999-09-06 BR BR9913429-2A patent/BR9913429A/pt not_active IP Right Cessation
- 1999-09-06 JP JP2000568876A patent/JP2002524470A/ja active Pending
- 1999-09-06 AU AU56412/99A patent/AU5641299A/en not_active Abandoned
- 1999-09-06 IL IL14152499A patent/IL141524A0/xx unknown
- 1999-09-06 TR TR2001/03405T patent/TR200103405T2/xx unknown
- 1999-09-06 TR TR2001/00651T patent/TR200100651T2/xx unknown
- 1999-09-06 EP EP99943138A patent/EP1107995A2/en not_active Withdrawn
- 1999-09-06 CA CA002341753A patent/CA2341753A1/en not_active Abandoned
- 1999-09-06 HR HR20010154A patent/HRP20010154A2/hr not_active Application Discontinuation
- 1999-09-06 EA EA200100311A patent/EA200100311A1/ru unknown
- 1999-09-06 PL PL99346861A patent/PL346861A1/xx not_active Application Discontinuation
-
2001
- 2001-02-26 BG BG105293A patent/BG105293A/bg unknown
- 2001-02-26 ZA ZA200101574A patent/ZA200101574B/en unknown
- 2001-03-02 NO NO20011102A patent/NO20011102L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9913429A (pt) | 2001-09-25 |
| WO2000014119A3 (en) | 2000-11-30 |
| AU5641299A (en) | 2000-03-27 |
| EP1107995A2 (en) | 2001-06-20 |
| HUP0104091A2 (hu) | 2002-03-28 |
| JP2002524470A (ja) | 2002-08-06 |
| KR20010072988A (ko) | 2001-07-31 |
| EA200100311A1 (ru) | 2001-08-27 |
| CA2341753A1 (en) | 2000-03-16 |
| HRP20010154A2 (en) | 2002-02-28 |
| PL346861A1 (en) | 2002-03-11 |
| GB9819411D0 (en) | 1998-10-28 |
| BG105293A (bg) | 2001-12-29 |
| NO20011102D0 (no) | 2001-03-02 |
| WO2000014119A2 (en) | 2000-03-16 |
| CN1315967A (zh) | 2001-10-03 |
| ZA200101574B (en) | 2002-02-26 |
| NO20011102L (no) | 2001-03-05 |
| IL141524A0 (en) | 2002-03-10 |
| TR200100651T2 (tr) | 2001-07-23 |
| ID28873A (id) | 2001-07-12 |
| MXPA01002349A (es) | 2003-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE383430T1 (de) | Rekombinante antikörper und immunkonjugate gezielt auf cd22-tragende zellen und tumoren | |
| EP1071460A4 (en) | INTERNALIZING ERB2 ANTIBODIES | |
| Krall et al. | A small‐molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors | |
| ATE246517T1 (de) | Konjugate zur behandlung von entzündungskrankheiten und von assozierter gewebeschädigung | |
| DE69830326D1 (de) | Iminbildende polysaccharide, deren herstellung und verwendung als zusatzmittel und immunstimulierende mittel | |
| ATE472338T1 (de) | Anti-cd70 antikörper-arzneimittelkonjugate und ihre verwendung zur behandlung von krebs | |
| FI982422A0 (fi) | Porfyriiniyhdisteitä, niiden konjugaatit sekä määritysmenetelmiä pohjautuen näiden konjugaattien käyttöön | |
| TR200003435T2 (tr) | Yeni parçacıklı formülasyonlar | |
| WO2004018000A3 (en) | Compositions and methods for treating cancer using maytansinoid cd44 antibody immonoconjugates and chemotherapeutic agents | |
| EP2353611A3 (en) | Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease | |
| DE69735368D1 (de) | Behandlung und diagnose von krebs | |
| ATE355079T1 (de) | Behandlung von prostata-krebs mit anti-erbb2 antikörpern | |
| TR200003161T2 (tr) | Poliol-IFN-Beta konjugatları | |
| DE60040981D1 (de) | BEHANDLUNG MIT ANTI-ErbB2 ANTIKÖRPERN | |
| AR035977A1 (es) | Inmunoconjugados de anticuerpos cd44 citotoxicos. | |
| RU92016354A (ru) | Композиция, способы лечения, способ предупреждения рецидива, способ усиления цитотоксической активности иммунотоксина, способ усиления цитотоксического действия конъюгата | |
| DE60113445D1 (de) | Substanzen mit verzweigten linkermolekülen | |
| FI924605A0 (fi) | Antikroppkonjugater foer behandling av neoplastiska sjukdomar | |
| TR200102041T2 (tr) | Progesteron reseptör bağlama aktif maddeleri olarak ikameli 2-arilimino heterosaykıllar | |
| ATE192047T1 (de) | Bicylclische, polyazamakrocyclocarbonsäure- komplexe, konjugate, herstellung und verwendung als kontraststoffe | |
| TR200103405T2 (tr) | İkiişlevli antikorlar ve bunların tümör-önleyici amilleri hedeflemede kullanımı. | |
| ATE280588T1 (de) | Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren | |
| Maison et al. | Improved chemical strategies for the targeted therapy of cancer | |
| TR200102944T2 (tr) | İntegrin reseptör ligandları | |
| WO2003017938A3 (en) | Conjugates targeted to target receptors |